Buffalo, NY USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Unique Gene Signature Predicts Potentially Lethal Prostate Cancers

Standard therapy for prostate cancer, the third-leading cause of cancer-related deaths in American men, is based on blocking androgens, the male sex hormones. However, for some men, prostate cancer recurs despite androgen-deprivation therapy. A team...
10-Jan-2017 2:05 PM EST Add to Favorites

Roswell Park Researchers Offer Novel Insight Into Genetic Changes Leading to Cancer

BUFFALO, N.Y. — Predisposition to cancer and cancer progression can result from gene mutations that cause elevated rates of genetic damage. Similarly, carcinogens, including some that are used in chemotherapy during cancer treatment, act by...
10-Jan-2017 11:05 AM EST Add to Favorites

New Study Highlights Role for Immune Cells in Cancer’s Ability to Evade Immunotherapy

One of the main reasons cancer remains difficult to treat is that cancer cells have developed a multitude of mechanisms that allow them to evade destruction by the immune system. One of these escape mechanisms involves a type of immune cell called...
29-Dec-2016 4:05 PM EST Add to Favorites

New Ovarian Cancer Immunotherapy Study Poses Question: Can Microbiome Influence Treatment Response?

EmeseZsirosinclinic.jpeg

A new clinical study underway at Roswell Park Cancer Institute is the first to test the combination of the immunotherapy pembrolizumab with two other drugs as treatment for recurrent epithelial ovarian cancer, and is also the first ovarian cancer...
28-Nov-2016 12:05 PM EST Add to Favorites

Roswell Park Gets FDA Approval for Clinical Study of Cuban Lung Cancer Vaccine, License for Joint U.S.–Cuba Commercial Partnership

cimavax-press-johnson_2.jpg

Spurred by NYS Trade Mission to Cuba in 2015, Buffalo cancer center will conduct a clinical trial with CIMAvax-EGF, groundbreaking immunotherapy for lung cancer developed in Cuba — becoming the first American center to receive FDA authorization to...
26-Oct-2016 2:05 PM EDT Add to Favorites

Study: Broader Availability of Information, Focus on Prevention Would Aid HPV Immunization Efforts

Currently, human papillomavirus (HPV) vaccination rates remain low across the U.S., with fewer than 40% of girls and just over 21% of boys receiving the recommended vaccine series. Research from Roswell Park Cancer Institute has identified barriers...
12-Oct-2016 1:05 PM EDT Add to Favorites

African-American and Hispanic Men Less Likely to Get Treatment for Prostate Cancer, Even with High-Risk Disease

African-American and Hispanic men in the United States are less likely to receive therapy for prostate cancer compared to Caucasian men — even when they have more aggressive disease, according to new research from Roswell Park Cancer Institute and...
7-Oct-2016 4:05 PM EDT Add to Favorites

Roswell Park Team Validates 10 Years of Outcomes Data for Bladder Cancer Surgeries

BUFFALO, N.Y. — What are the factors that add up to the best outcomes for patients who have surgery to treat cancer? Looking for a better way to measure quality of care and share best practices in surgical oncology, a team from Roswell Park Cancer...
4-Oct-2016 12:05 PM EDT Add to Favorites

Our Experts on Newswise

Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch

22-Sep-2016 3:05 PM EDT

Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk

27-Oct-2015 5:05 PM EDT

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.




Chat now!